<DOC>
	<DOCNO>NCT02152228</DOCNO>
	<brief_summary>This observational , international , open label , pilot study evaluate safety , tolerability efficacy oral PTH ( 1-34 ) preparation produce Entera Bio adult hypoparathyroid volunteer .</brief_summary>
	<brief_title>A Pilot Study Assess Safety Efficacy Oral PTH ( 1-34 ) Treatment Hypoparathyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypoparathyroidism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Confirmed diagnosis primary hypoparathyroidism 1 year . Currently take &gt; 1.0 gram Calcium/day correlate alpha D3 dose . 25 ( OH ) D level â‰¥ 20 ng/ml . Signed informed consent . BMI 18 30 kg/m2 , inclusive . Full blood count within reference range per WHO criteria . Minor abnormality assess Principle Investigator discussion sponsor patient may still enter felt `` clinical importance '' . Abnormalities due hypoparathyroidism relate acceptable constitute exclusion . Patients significant liver function impairment ( liver enzymes x3 upper limit normal range per WHO criteria ) exclude . Subjects able adhere visit schedule protocol requirement . Haemoglobin &lt; 12 g/dL ( female ) / &lt; 13gm/dL ( male ) [ low limit reference range 1215 &amp; 1317 ] Impaired renal function impair liver function ; ALT &gt; 38 international unit per liter ( IU/L ) , ALP &gt; 125 IU/L Significant drug alcohol abuse assess Principal Investigator Allergy soy bean product Presence kidney urinary tract stone Concurrent therapy , Investigator 's opinion , would interfere evaluation safety efficacy study medication . Treatment investigational product within last 30 day , enrollment intention enroll active study involve use investigational device drug . Presence condition circumstance , judgment Investigator , might increase risk patient decrease chance obtain satisfactory data achieve objective study . Active infection Pregnancy suspect pregnancy . Female subject must negative serum pregnancy test screen willing able use medically acceptable method birth control ( reliable use oral contraceptive , nonhormonal intrauterine device condom , diaphragm condom , condom spermicide ) screen visit study termination visit declare abstain sexual intercourse screen visit study termination visit surgically sterile ( undergone bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) postmenopausal . Postmenopausal woman define woman menstruation cessation 12 consecutive month prior sign inform consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>